Table 3.
Mean values and standard deviation (SD) for the whole sample of Gastrointestinal symptoms and the delta changes between the run in phase and the intake phase (week 3-4)
| Whole sample size (N = 47) |
Placebo |
Perilla |
Placebo |
Perilla |
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Run In | Intake week 1-2 | Intake week 3-4 | p value (ANOVA) | Run In | Intake week 1-2 | Intake week 3-4 | p value (ANOVA) | Delta week 3-4 to run in | Delta week 3-4 to run in | Comparison between groups (95% CI) | |
| Bloating |
1.45 |
1.44 |
1.2 |
0.0733 |
1.42 |
1.28 |
0.98 |
0.0003 |
-0.25 |
-0.44 |
-0.194 to 0.562 |
| SD |
0.74 |
0.72 |
0.77 |
|
0.81 |
0.64 |
0.78 |
|
0.71 |
0.56 |
|
| Passage of gas |
1.47 |
1.57 |
1.37 |
0.2284 |
1.6 |
1.5 |
1.3 |
0.0264 |
-0.10 |
-0.30 |
-0.177 to 0.577 |
| SD |
0.66 |
0.53 |
0.62 |
|
0.77 |
0.62 |
0.74 |
|
0.62 |
0.66 |
|
| GI rumbling |
1.51 |
1.33 |
1.18 |
0.0635 |
1.64 |
1.27 |
1.09 |
0.0014 |
-0.33 |
-0.55 |
-0.251 to 0.685 |
| SD |
0.86 |
0.91 |
0.83 |
|
0.85 |
0.6 |
0.81 |
|
0.71 |
0.87 |
|
| Feeling of fullness |
1.08 |
1.05 |
0.83 |
0.0987 |
1.03 |
0.84 |
0.67 |
0.0152 |
-0.24 |
-0.36 |
-0.288 to 0.515 |
| SD |
0.8 |
0.59 |
0.62 |
|
0.77 |
0.63 |
0.63 |
|
0.64 |
0.72 |
|
| Abdominal discomfort |
1.15 |
1.06 |
0.84 |
0.0345 |
1.25 |
0.92 |
0.71 |
0.0004 |
-0.31 |
-0.54 |
-0.156 to 0.621 |
| SD | 0.93 | 0.84 | 0.81 | 0.86 | 0.61 | 0.74 | 0.55 | 0.75 | |||
For the comparison within group p values of repeated measures ANOVA and for the comparison between groups the 95% confidence intervals of differences are shown.